AN OBSERVATIONAL POST-AUTHORIZATION MODIFIED PRESCRIPTION-EVENT MONITORING SAFETY STUDY TO MONITOR THE SAFETY AND UTILIZATION OF EXENATIDE ONCE WEEKLY (BYDUREON®) IN THE PRIMARY CARE SETTING IN ENGLAND

First published 21/01/2014

Last updated 16/02/2024

EU PAS number:

EUPAS5599

Study

Finalised

Documents

Study protocol

Initial protocol

Exenatide_M_PEM_full_protocol_FINAL_14_11_14_v3.2_ EUPAS

English (722.7 KB - PDF)View document

Study results

Exenatide M-PEM Final Report_v3.0 ENCePP_Redacted

English (4.2 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs